Cargando…
Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods
Recently, many new diagnostic biomarkers have been developed for colorectal cancer. We chose 2 methods with high diagnostic efficiency, the detection of serum microRNA and metabolomics based on gas chromatography/mass spectrometry (GC/MS), and aimed to establish appropriate models. We reviewed the d...
Autores principales: | Liu, Hai‐Ning, Liu, Tao‐Tao, Wu, Hao, Chen, Yan‐Jie, Tseng, Yu‐Jen, Yao, Can, Weng, Shu‐Qiang, Dong, Ling, Shen, Xi‐Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891204/ https://www.ncbi.nlm.nih.gov/pubmed/29363233 http://dx.doi.org/10.1111/cas.13514 |
Ejemplares similares
-
Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma
por: Liu, Hai-Ning, et al.
Publicado: (2017) -
Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer
por: Liu, Hai-Ning, et al.
Publicado: (2018) -
Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis
por: Yao, Can, et al.
Publicado: (2018) -
Prognostic Value of microRNA Signature in Patients with Gastric Cancers
por: Liu, Hai-Ting, et al.
Publicado: (2017) -
MicroRNA and metabolomics signatures for adrenomyeloneuropathy disease severity
por: Turk, Bela Rui, et al.
Publicado: (2022)